Treatment with electromagnetic fields improves dual-task performance (Talking while walking) in multiple sclerosis

References

• Arnett P. A., Rao S. M., Bernardin L., Grafman J., Yetkin F. Z., Lobeck L. Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis. Neurology 1994; 44: 420–425
   PubMed Web of Science ®Google Scholar
• Averbuch-Heller L., Shalev A. Y., Abramowitz M. Z. An unusual presentation of multiple sclerosis. American Journal of Psychiatry 1992; 149: 410–411
   PubMed Web of Science ®Google Scholar
• Baddeley A., Logie R., Bressi S., Delia Salla S., Spinnler H. Dementia and working memory. Quarterly Journal of Experimental Psychology 1986; 38A: 603–618
   Web of Science ®Google Scholar
• Beatty W. W., Goodkin D. E., Beatty P. A., Monson N. Frontal lobe dysfunction and memory impairment in patients with chronic progressive multiple sclerosis. Brain and Cognition 1989; 11: 73–86
   PubMed Web of Science ®Google Scholar
• Brown R., Jahanshahi M., Marsden C. The execution of bimanual movements in patients with Parkinson's, Huntington's and cerebellar disease. Journal of Neurology Neurosurgery and Psychiatry 1993; 56: 295–297
   PubMed Web of Science ®Google Scholar
• Brozoski T. J., Brown R. M., Rosvold H. E., Goldman P. S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 1979; 205: 929–932
   PubMed Web of Science ®Google Scholar
• Camicioli R., Howieson D., Lehman S., Kaye J. Talking while walking: the effect of a dual task in aging and Alzheimer's disease. Neurology 1997; 48: 955–958
   PubMed Web of Science ®Google Scholar
• Claveria L. E., Curzon G., Harrison M. J. G., Kantamaneni B. D. Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1974; 37: 715–718
   PubMed Web of Science ®Google Scholar
• Comings D. E. Tourette syndrome and human behavior. Hope Press, Duarte, CA 1990; 341–361
   Google Scholar
• Davidson D., Pullar I. A., Mawdsley C., Kinloch N., Yates C. M. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry 1977; 40: 741–745
   PubMed Web of Science ®Google Scholar
• Filley C. M., Heaton R. K., Nelson L. M., Burks J. S., Franklin G. M. A comparison of dementia in Alzheimer's disease and multiple sclerosis. Archives of Neurology 1989; 46: 157–161
   PubMedGoogle Scholar
• Fleminger S. Control of simultaneous movement distinguishes depressive motor retardation from Parkinson's disease and neuroleptic parkinsonism. Brain 1992; 115: 1459–1480
   PubMed Web of Science ®Google Scholar
• Franklin G. M., Nelson L. M., Filley C. M., Heaton R. K. Cognitive loss in multiple sclerosis. Case reports and review of the literature. Archives of Neurology 1989; 46: 162–167
   PubMed Web of Science ®Google Scholar
• Johansson B., Ross B. E. 5-hydroxyindoleacetic acid and homovanillic acid in CSF of patients with neurological disease. European Neurology 1977; 11: 37–45
   Web of Science ®Google Scholar
• Kolb B., Whishaw I. Q. Fundamentals of human neuropsychology. W.H. Freeman and Company, New York 1990; 474–477
   Google Scholar
• Leonard G., Milner B., Jones L. Performance on unimanual and bimanual tapping tasks by patients with lesions of the frontal or temporal lobe. Neuropsychologia 1988; 26: 79–91
   PubMed Web of Science ®Google Scholar
• Mendez M. F., Frey W. H. Multiple sclerosis dementia. Neurology 1992; 42: 696
   PubMed Web of Science ®Google Scholar
• Milner B. Some effects of frontal lobectomy in man. The frontal granular cortex and behavior, J. M. Warren, K. Akert. McGraw-Hill, New York 1964; 313–334
   Google Scholar
• Milner B., Petrides M. Behavioural effects of frontal lobe lesions in man. Trends in Neurosciences 1984; 7: 403–107
   Web of Science ®Google Scholar
• Nutt J., Marsden C., Thompson P. Human walking and higher level gait disorders, particularly in the elderly. Neurology 1993; 43: 268–279
   PubMed Web of Science ®Google Scholar
• Persad C., Giordani B., Chen H. C. Neuropsychological predictors of complex obstacle avoidance in healthy older adults. Journal of Gerontology 1995; 50B: P272–P277
   Google Scholar
• Ramier A. M., Hecan H. Role respeetif des atteintes frontales et de la lateralisation lesionnelle dans les deficits de la “fluence verbale.”. Revue de Neurologie 1970; 123: 17–22
   PubMed Web of Science ®Google Scholar
• Rao S. M. Neuropsychology of multiple sclerosis: a critical review. Journal of Clinical and Experimental Neuropsychology 1986; 8: 503–542
   PubMed Web of Science ®Google Scholar
• Roelcke U., Kappos L., Lechner-Scott J., Brunnschweiler H., Huber S., Ammann W., Plohmann A., Dellas S., Maguire R. P., Missimer J., Radu E. W., Steck A., Leenders K. L. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: A 18F-fluorodeoxyglucose positron emission tomography study. Neurologv 1997; 48: 1566–1571
   PubMed Web of Science ®Google Scholar
• Rosen W. G. Verbal fluencv in aging and dementia. Journal of Clinical Neuropsychology 1980; 2: 135–146
   Google Scholar
• Sandyk R. Successful treatment of multiple sclerosis with magnetic fields. International Journal of Neuroscience 1992; 66: 237–250
   PubMed Web of Science ®Google Scholar
• Sandyk R. Improvement in word-fluency performance in patients with multiple sclerosis by electromagnetic fields. International Journal of Neuroscience 1994a; 79: 75–90
   PubMed Web of Science ®Google Scholar
• Sandyk R. Long term beneficial effects of weak electromagnetic fields in multiple sclerosis. International Journal of Neuroscience 1995; 83: 45–57
   PubMed Web of Science ®Google Scholar
• Sandyk R., Derpapas K. Magnetic fields normalize visual and brainstem auditory evoked potentials in multiple sclerosis. International Journal of Neuroscience 1993a; 68: 241–253
   PubMedGoogle Scholar
• Sandyk R., Derpapas K. Successful treatment of an acute exacerbation of multiple sclerosis by external magnetic fields. International Journal of Neuroscience 1993a; 70: 97–105
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P. Resolution of longstanding symptoms of multiple sclerosis by application of picotesla range magnetic fields. International Journal of Neuroscience 1993; 70: 255–269
   PubMed Web of Science ®Google Scholar
• Sandyk R., Iacono R. P. Multiple sclerosis: Improvement of visuoperceptive functions by picotesla range magnetic fields. International Journal of Neuroscience 1994a; 74: 177–189
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P. Improvement by picotesla range magnetic fields of perceptual-motor performance and visual memory in a patient with chronic progressive multiple sclerosis. International Journal of Neuroscience 1994b; 78: 53–66
   PubMed Web of Science ®Google Scholar
• Sonninen V., Riekkinen P., Rinne U. K. Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology 1973; 23: 760–763
   PubMed Web of Science ®Google Scholar
• Tabaddor K., Wolfson L. I., Sharpless N. S. Ventricular fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in patients with movement disorders. Neurologv 1978; 28: 1249–1253
   PubMed Web of Science ®Google Scholar
• Thurstone L., Thurstone T. The Chicago tests of primary mental abilities. Science Research Associates, Chicago 1943
   Google Scholar
• White R. F. Emotional and cognitive correlates of multiple sclerosis. Journal of Neuropsychiatry 1990; 2: 422–428
   PubMedGoogle Scholar